Enhanced bone formation by transforming growth factor-β1-releasing collagen/chitosan microgranules

Journal of Biomedical Materials Research - Part A

Volumn 76, Issue 3, 2006, Pages 530-539

  Lee, Jue Yeon ^a,b   Kim, Kyoung Hwa ^b   Shin, Seung Yoon ^b   Rhyu, In Chul ^b   Lee, Yong Moo ^b   Park, Yoon Jeong ^b   Chung, Chong Pyoung ^b   Lee, Seung Jin ^a  

^a Ewha Womans University   (South Korea)

^b School of Dentistry   (South Korea)

Author keywords

Bone formation; Bone substitutes; Chitosan; Collagen; Transforming growth factor (TGF) 1

Indexed keywords

CELL CULTURE; CHITIN; COLLAGEN; ETHANOL; SCANNING ELECTRON MICROSCOPY; SODIUM COMPOUNDS;

BONE FORMATION; BONE SUBSTITUTES; CHITOSAN; TRANSFORMING GROWTH FACTOR (TGF)-Β1;

BONE;

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALCOHOL; ALKALINE PHOSPHATASE; CHITOSAN; COLLAGEN; COLLAGEN TYPE 1; IODINE 125; OSTEOCALCIN; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; SODIUM HYDROXIDE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE BLOOD FLOW; BONE DEFECT; BONE GRAFT; BONE GROWTH; BONE REGENERATION; CALVARIA; CELL PROLIFERATION; CELL STRUCTURE; COMPOSITE MATERIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG RELEASE; ENZYME ACTIVITY; IN VIVO STUDY; MALE; MICROGRANULE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PARTICLE SIZE; PROTEIN DETERMINATION; RABBIT; SCANNING ELECTRON MICROSCOPY; TISSUE ENGINEERING; TISSUE REPAIR; VASCULARIZATION;

ANIMALS; BONE REGENERATION; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CHITOSAN; COLLAGEN; DELAYED-ACTION PREPARATIONS; FRACTURES, BONE; HUMANS; MALE; MICE; MICROSPHERES; OSTEOBLASTS; OSTEOGENESIS; RABBITS; SKULL; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33645292061     PISSN: 00219304     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.30434     Document Type: Article

References (35)

1. De Boer HH. History of bone grafts. Clin Orthop Relat Res 1998;226:292-298.
2. Suchanek W, Yoshimura M. Processing and properties of hydroxyapatite-based biomaterials for use as hard tissue replacement implants. J Mater Res 1998;13:94-117.
3. Burg KJL, Porter S, Kellam JF. Biomaterial developments for bone tissue engineering. Biomaterials 2000;21:2347-2359.
4. Pilliar RM, Filiaggi MJ, Wells JD, Grynpas MD, Kandel RA. Porous calcium polyphosphate scaffolds for bone substitute applications: in vitro characterization. Biomaterials 2001;22:963-972.
5. Boyan BD, Lohmann CH, Romero J. Bone and cartilage tissue engineering. Clin Plast Surg 1999;26:629-645.
6. Mikos AG, Thorsen AJ, Czersonka LA, Bao Y, Langer R, Winslow DN, Vacanti JP. Preparation and characterization of poly(L-lactic acid) foams. Polymer 1994;35:1068-1077.
7. Zhang R, Ma PX. Poly(alpha-hydroxyl acids)/hydroxyapatite porous composites for bone-tissue engineering. I. Preparation and morphology. J Biomed Mater Res 1999;44:446-455.
8. Shea LD, Wang D, Franceschi RT, Mooney DJ. Engineered bone development from a pre-osteoblast cell line on three-dimensional scaffolds. Tissue Eng 2000;6:605-617.
9. Ishaug SL, Crane GM, Miller MJ, Yasko AW, Yaszemski MJ, Mikos AG. Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res 1997;36:17-28.
10. Ver M, Mauduit J, Li S. Biodegradation of PLA/GA polymers increasing complexity. Biomaterials 1994;15:1209-1213.
11. Suh F, Howard JK, Mathew WT. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review. Biomaterials 2002;21:31-36.
12. Aiedeh K, Gianasi E, Orenti I, Zecchi V. Chitosan microcapsules as controlled release systems for insulin. J Microencapsul 1997;14:567-576.
13. Muzzarelli R, Biagini G, Pugnaloni A, Filippini O, Baldassarre V, Castaldini C, Rizzoli C. Reconstruction of parodontal tissue with chitosan. Biomaterials 1989;10:598-603.
14. Tan W, Krishnaraj R, Desai TA. Evaluation of nanostructured composite collagen-chitosan matrices for tissue engineering. Tissue Eng 2001;7:203-210.
15. McPherson JM. The utility of collagen-based vehicles in delivery of growth factors for hard and soft tissue wound repair. Clin Mater 1992;9:225-234.
16. Rao KP. Recent developments of collagen-based materials for medical applications and drug delivery systems. J Biomater Sci Polym Ed 1995;7:623-645.
17. Ellis DL, Yannas IV. Recent advances in tissue synthesis in vivo by use of collagen-glycosaminoglycan copolymers. Biomaterials 1996;17:291-299.
18. Linkhart TA, Mohan S, Baylink DJ. Growth factors for bone growth factor and repair: IGF, TGF-β1 and BMP. Bone 1996;19(Suppl):1S-2S.
19. Nimi ME. Polypeptide growth factors: targeted delivery systems. Biomaterials 1997;18:1201-1225.
20. Bonewald LF, Dallas SL. Role of active and latent transforming growth factor β in bone formation. J Cell Biochem 1994;55:350-357.
21. De Visser KE, Kast WM. Effects of TGF-β on the immune system: implications for cancer immunotherapy. Leukemia 1999;13:1188-1199.
22. Lu L, Yaszemski MJ, Mikos AG. TGF-β1 release from biodegradable polymer microparticles: its effects on marrow stromal osteoblast function. J Bone Joint Surg Am 2001;83:S82-91.
23. Peter SJ, Lu L, Kim DJ, Stamatas GN, Miller MJ, Yaszemski MJ, Mikos AG. Effects of transforming growth factor beta 1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates. J Biomed Mater Res 2000;50:452-462.
24. Beck LS, DeGuzman L, Lee WP, Xu Y, Siegel MW, Amento EP. One systemic administration of transforming growth factor-beta 1 reverse age- or glucocorticoid-impaired wound healing. J Clin Invest 1993;92:2841-2849.
25. Mossman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
26. Hong L, Tabata Y, Miyamoto S, Yamamoto M, Yamada K, Hashimoto N, Ikada Y. Bone regeneration at rabbit skull defects treated with transforming growth factor β1 incorporated in hydrogels with different biodegradabilities. J Neurosurg 2000;92:315-325.
27. Evans EJ, Toxicity of HA in vitro: the effect of particle size. Biomaterials 1991;12:574-576.
28. Boyan BD, Hummert TW, Dean DD, Schwartz Z. Role of material surfaces in regulating bone and cartilage cell response. Biomaterials 1996;17:137-146.
29. Sun JS, Tsuang YH, Chang WHS, Li J, Liu HC, Lin FH. Effects of hydroxyapatite particle size on myoblasts and fibroblasts. Biomaterials 1996;18:683-690.
30. Ishaug SL, Yaszemski MJ, Bizios R, Mikos AG. Osteoblast function on synthetic biodegradable polymers. J Biomed Mater Res 1994;28:1445-1453.
31. Quarles LD, Yohay DA, Lever LW, Caton R, Wenstrup R. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J Bone Miner Res 1992;7:683-692.
32. Ibbotson KJ, Orcutt CM, Anglin AM, D'Souza SM. Effects of transforming growth factors beta 1 and beta 2 on a mouse clonal, osteoblastlike cell line MC3T3-E1. J Bone Miner Res 1989;4:37-45.
33. Harris SE, Bonewald LF, Harris MA, Sabatini M, Dallas S, Feng JQ, Ghosh-Choudhury N, Wozeny J, Mundy GR. Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long term cultures of fetal rat calvarial osteoblasts. J Bone Miner Res 1994;9:855-863.
34. Jauschka PV, Lian JB, Gallop PM. Direct identification of the calcium-binding amino acid, γ-carboxyglutamate, in mineralized bone. Proc Natl Acad Sci USA 1975;72:3925-3929.
35. Ueda H, Hong L, Yamamoto M, Shigeno K, Inoue M, Toba T, Yoshitani M, Nakamura T, Tabata Y, Shimizu Y. Use of collagen sponge incorporating transforming growth factor-β1 to promote bone repair in skull defects in rabbits. Biomaterials 2002;23:1003-1010.